Brain Imaging and Blood Biomarker Abnormalities in Children With Autosomal Dominant Alzheimer Disease

Authors:

Abstract
Alzheimer disease (AD) is now conceptualized as a sequence of physiological changes that begins during preclinical stages of the disease and becomes more severe in clinical stages of the disorder.1-4 Proposed research diagnostic criteria for preclinical AD use imaging and molecular biomarkers to identify asymptomatic individuals with cerebral amyloidosis and evidence of early neurodegeneration for potential intervention trials.5,6 We and others have suggested that there may be even earlier brain alterations in persons at risk for AD, some of which may be developmental and provide a foothold for fibrillar amyloid-β (Aβ) deposition and other progressive physiological changes associated with AD.4,7